Tag archive for ‘NuPathe Inc.(Nasdaq: PATH)’
Shiri Habib-Valdhorn On Wednesday, January 8th, 2014

Teva Offers $114 Million For Biotechnology company NuPathe

– In a notice to the SEC, biotech company NuPathe said that Teva is offering $3.65 per share, compared with yesterday’s closing price of $3.23. – The NuPathe migraine patch is worn on More...

Wordpress site Developed by Fixing WordPress Problems